Bart Devoldere becomes a member of the NORC Data Enclave research group

Vlerick researcher Bart Devoldere has recently become an official member of the NORC Data Enclave research group. He owes his membership to winning a Kauffman Foundation research grant.

The NORC Data Enclave provides a confidential, protected environment within which authorised researchers can access sensitive microdata remotely. While public use data can be disseminated in a variety of ways, there is a more limited range of options for disseminating sensitive microdata that have not been fully de-identified for public use. The NORC Data Enclave provides partner organisations a secure platform where they can both host and build a research community around their datasets. Such a community is the first step in developing a core body of knowledge about the data, fostering replication of research, and ensuring that research based on the data is acceptable to academic journals and policymakers. Enclave researchers are provided with a research environment, that features discussion forums, wikis, blogs, and instant messaging. These environments facilitate collaboration amongst geographically dispersed researchers, helping them share information and develop a knowledge infrastructure around the data.

Bart Devoldere: “The NORC Data Enclave – better known as the Kauffman Firm Survey – is important to be able to do research on how young (especially technological) companies are organised and how successful they are during their first years of existence. As for me in particular, I’m doing research on how start-ups can make use of their location and how they can respond to present spillovers in the field of knowledge and human capital in their proximity. This longitudinal survey offers a unique insight into how starting companies organise their HR, which functional domains they mainly invest in (sales, R&D, HR, etc.), specific qualities of the owner, and how companies attract capital, just to name a few.”

Related news

  1. How a CEO thinks, determines what he does

    Date: 10/07/2018
    Category: Research News
    Corporate strategy, managerial discretion, commitment to the status quo, temporal focus, CEO succession, legitimacy effects of CSR, controlling instruments in start-ups, cultural differences in diversity management – Kerstin Fehre’s research interests seem broad and varied. “But they can all be summarised under the umbrella of strategic decision-making”, she says smiling. Kerstin was recently appointed professor of strategy. She will also be closely involved in the new Centre for Excellence in Adaptive Strategy.
  2. Technology is set to transform the pharmaceutical industry

    Date: 11/04/2018
    Category: Research News
    Recently Professor Zeynep Erden joined our Healthcare Management Centre. She is an innovation and strategy scholar, with a special focus on technology and knowledge management in the pharmaceutical industry. “I try to understand what fosters or hinders innovation and which innovation strategies lead to competitive advantages for pharmaceutical companies. I’m particularly interested in how new technologies change the way organisations innovate.” She identifies three major trends that are currently shaping the innovation strategies of pharmaceutical companies: patients first, advanced data analytics and a call for better and cheaper medicines.
All articles